Zhongming Qiu
Clinical trials sponsored by Zhongming Qiu, explained in plain language.
-
New drug hope for rare muscle disease
Disease control Not yet recruitingThis study tests a drug called telitacicept for people with inflammatory myopathy, a condition where the immune system attacks muscles. The goal is to see if the drug is safe and can help control the disease. About 30 adults who haven't responded well to standard treatments will …
Phase: PHASE2, PHASE3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
New drug ripertamab tested for muscle weakness disease
Symptom relief Not yet recruitingThis early-stage trial tests if ripertamab can safely improve daily living for people with generalized myasthenia gravis, a condition causing muscle weakness. About 20 adults will receive a single infusion of ripertamab or a placebo and be monitored for 13 weeks. The main goal is…
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Symptom relief
Last updated May 26, 2026 11:32 UTC